West Pharmaceutical Services, Inc. Common Stock (NY:WST)Price and VolumeDetailed Quote
Top NewsMore News
S&P 500 Unusual Volume Movers for Nov. 2, 2026 ↗
November 02, 2026
Performance
52-Week Range
10.9% below 52-week high
390.30
223.8352W Low
438.2752W High
1 Week
7.2% below 1-week high
387.711W Low
420.661W High
West Pharmaceutical Services, Inc. Common Stock (WST) traded between $223.83 and $438.27 over the past 52 weeks and last traded at $390.30, 10.9% below its 52-week high. Over the past week it ranged between $387.71 and $420.66.
Past 12 Months
-6.6%
-0.8%
+10.5%
+23.3%
+41.2%
+51.4%
1W
-$27.50
1M
-$3.18
3M
+$37.22
6M
+$73.88
YTD
+$113.90
1Y
+$132.53
WST was +51.4% over the past year, +23.3% over six months, +41.2% year to date, -6.6% in the last week.
12 Months vs Market
WST
DIA
SPY
QQQ
IWM
Over the past 12 months WST returned +51.4% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.
Volume & Liquidity
1.01× 3-mo avg
Today 623,503
3-mo avg 617.7K
1W
1M
3M
6M
YTD
1Y
WST most recently traded 623,503 shares against a 3-month average daily volume of 617.7K. More NewsRead More
1 healthcare stock with impressive fundamentals and 2 we ignore
November 01, 2026
Via StockStory
Topics
Economy
Via MarketBeat
Topics
Earnings
S&P 500 Unusual Volume Movers for October 29, 2026 ↗
October 29, 2026
S&P 500 Top Movers: Today's US Session Gainers and Losers ↗
October 29, 2026
West (WST) Q3 2026 Earnings Call Transcript ↗
October 29, 2026
Via The Motley Fool
Topics
Earnings
S&P 500 Gap Movers: October 29, 2026 Session ↗
October 29, 2026
West Pharmaceutical Services earnings: what to look for from WST
October 27, 2026
Via StockStory
Topics
Artificial Intelligence
3 Low-Volatility Stocks We’re Skeptical Of
October 19, 2026
Via StockStory
Topics
Economy
1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges
October 05, 2026
Via StockStory
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)
September 30, 2026
Via StockStory
Topics
Economy
1 S&P 500 Stock with Exciting Potential and 2 We Ignore
September 22, 2026
Via StockStory
1 Surging Stock with Solid Fundamentals and 2 That Underwhelm
September 21, 2026
Via StockStory
Topics
Economy
3 Profitable Stocks with Warning Signs
September 10, 2026
Via StockStory
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Ignore
September 02, 2026
Via StockStory
Topics
Economy
1 Mid-Cap Stock on Our Buy List and 2 Facing Headwinds
September 01, 2026
Via StockStory
Topics
Economy
1 Healthcare Stock with Exciting Potential and 2 We Avoid
August 27, 2026
Via StockStory
Topics
Economy
3 Cash-Heavy Stocks We Approach with Caution
July 31, 2026
Via StockStory
Topics
Economy
3 Reasons to Avoid WST and 1 Stock to Buy Instead
July 31, 2026
Via StockStory
Frequently Asked QuestionsIs West Pharmaceutical Services, Inc. Common Stock publicly traded?
Yes, West Pharmaceutical Services, Inc. Common Stock is publicly traded.
What exchange does West Pharmaceutical Services, Inc. Common Stock trade on?
West Pharmaceutical Services, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for West Pharmaceutical Services, Inc. Common Stock?
The ticker symbol for West Pharmaceutical Services, Inc. Common Stock is WST on the New York Stock Exchange
What is the current price of West Pharmaceutical Services, Inc. Common Stock?
The current price of West Pharmaceutical Services, Inc. Common Stock is 390.30
When was West Pharmaceutical Services, Inc. Common Stock last traded?
The last trade of West Pharmaceutical Services, Inc. Common Stock was at 11/20/26 07:00 PM ET
What is the market capitalization of West Pharmaceutical Services, Inc. Common Stock?
The market capitalization of West Pharmaceutical Services, Inc. Common Stock is 27.24B
How many shares of West Pharmaceutical Services, Inc. Common Stock are outstanding?
West Pharmaceutical Services, Inc. Common Stock has 27B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>